Probiotics for obesity: a new clinical trial
![Probiotics for obesity: a new clinical trial]()
This randomized, double-blinded and placebo-controlled study examined the effects of MED-02, a combination of two Limosilactobacillus fermentum strains (MG4231 and MG4244) in overweight or obese subjects. 100 participants have been recruited and received the placebo or MED02 (5 x 10(9) CFU/day) for 12 weeks. Reductions in body fat mass (-1166.82 g vs. -382.08 g; p = …A new ingredient containing casein, iron and phosphate recognized as safe by EFSA
![A new ingredient containing casein, iron and phosphate recognized as safe by EFSA]()
EFSA has published a scientific opinion on iron milk proteinate, a combination of casein, iron and phosphate. EFSA was also asked to address the bioavailability of iron from this source. The novel food is produced from iron salts (ferric chloride and ferric sulfate), sodium caseinate and potassium orthophosophate. It contains 2.4% iron. The available studies substantiate …Europe: draft text on green tea extracts containing EGCG
![Europe: draft text on green tea extracts containing EGCG]()
The draft Commission Regulation (EU) amending Annex III to Regulation (EC) No 1925/2006 as regards green tea extract containing EGCG has been voted positively by the Member States in June 2022 and has been sent to the European Parliament for a 3-month period for scrutiny procedure. Next step: The final text should be published in the Official Journal …Justification of the non-novel food character of each plant extract
![Justification of the non-novel food character of each plant extract]()
Recently in Europe, many discussions recall the need to be able to justify the non-novel food character of each plant extract used in food supplements. On 27 May 2022, the Italian Authorities published a circular on “Indications on the use of plants and their parts in food supplements to ensure the safety and protection of citizens”, which …EFSA: Cannabidiol novel food evaluations on hold pending new data
![EFSA: Cannabidiol novel food evaluations on hold pending new data]()
Following the submission of numerous applications for cannabidiol (CBD) under the novel food regulation (19 received by EFSA, but more than 150 sent to the Commission), the Commission asked EFSA to give its opinion on whether CBD consumption is safe for humans. According to its statement published on 7 June 2022, EFSA cannot currently establish the safety of …
